Life Sciences Financings and Commentary #5

Axial
5 min readMay 1, 2020

Get these analyses to your inbox — https://axialfc.substack.com/ This is a newsletter for new financing events with some simple analysis. More well thought out work can be found at — https://axial.substack.com/ I figured that there is a diversity across desire for frequency of emails.

Axial invests and partners in early-stage life sciences companies. If you or someone you know has a great idea or company in life sciences, Axial would be excited to get to know you and possibly invest in your vision and company — info@axialsprawl.com

Life Sciences Financings and Commentary #5 — April 25, 2020 — May 1, 2020

Financings

Number of deals: 22 & Total capital invested: $838M

- Actym Therapeutics raised $34M co-led by Boehringer Ingelheim Venture Fund and Panacea Venture to get their attenuated microbial therapeutic into the clinic with the goal of turning cold tumors hot.

- Avalyn Pharma raised $35.5M led by Norwest Venture Partners to develop drugs for pulmonary diseases.

- Bestow raised $50M led by Valar Ventures to build a life insurance product that doesn’t require a medical exam — https://news.crunchbase.com/news/bestow-closes-50m-series-b-for-digital-life-insurance-sees-800-yoy-revenue-growth/

- BuyMed raised $2.5M led by Sequoia Capital India to build an online pharmaceutical marketplace in Vietnam —…

--

--